Please assess the completion status of the following clinical trial:

Trial Title: Comparing Ketamine and Morphine in the Treatment of Acute Fracture Pain

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eligible Long bone fractures. This will include:~* Humerus~* Tibia~* Fibula~* Femur~* Radius~* Ulna~Exclusion Criteria:~* Injuries older than 24 hours~* Avulsion fractures~* History of substance abuse~* History of chronic opioid dependence~* Pregnancy~* Demonstrates signs of intoxication~* Allergic to ketamine or opioids~* Patients unable to consent~* Hemodynamically unstable (SBP \>180mmHg or \<100mgHg, HR \>130bpm, Respiratory rate \<10, oxygen saturations \<90%

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Ketamine (Type: EXPERIMENTAL): Ketamine is a dissociative agent that is thought to modulate pain by binding to NMDA receptors. Participants assigned to the ketamine arm will be given 0.4 mg/kg IV of ketamine (40 mg maximum).
- Morphine (Type: EXPERIMENTAL): Morphine is an opioid that acts on opioidergic receptors to modulate pain. Participants in the opioid arm will receive 0.1 mg/kg IV of morphine (10 mg maximum).

Based on this trial design, predict the completion outcome and termination type (if applicable).